‘The current environment does not protect clinical studies.’

CMA wants new ways to protect intellectual property in complementary medicines, saying this would attract research investment Complementary Medicines Australia (CMA) says that it has recommended a formula for successful innovation, in its response to the review by the Department of Industry, Innovation and Science. This formula aims to develop better intellectual property laws for